<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33989509</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Sep</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>3247</StartPage>
          <EndPage>3258</EndPage>
          <MedlinePgn>3247-3258</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2021.1911514</ELocationID>
        <Abstract>
          <AbstractText>Auto-disable (AD) syringes are specifically designed to prevent syringe reuse. However, the notion that specific AD syringe designs may be unsafe due to reuse concerns related to the syringe's activation point has surfaced. We conducted a systematic review for evidence on the association between AD syringe design and syringe reuse, adverse events following immunization (AEFI), or blood borne virus (BBV) transmission. We found no evidence of an association between AD syringe design and unsafe injection practices including syringe reuse, AEFIs, or BBVs. Authors of three records speculated about the possibility of AD syringe reuse through intentionally defeating the disabling mechanism, and one hinted at the possibility of reuse of larger-than-required syringes, but none reported any actual reuse instance. In contrast to AD syringes, standard disposable syringes continue to be reused; therefore, the global health community should expand the use of AD syringes in both immunization and therapeutic context as an essential strategy for curbing BBV transmission.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ali Khan</LastName>
            <ForeName>Anokhi</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-3671-4550</Identifier>
            <AffiliationInfo>
              <Affiliation>IRD Pakistan, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Munir</LastName>
            <ForeName>Mehr</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-2824-1263</Identifier>
            <AffiliationInfo>
              <Affiliation>IRD Pakistan, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miraj</LastName>
            <ForeName>Fatima</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0002-4636-5625</Identifier>
            <AffiliationInfo>
              <Affiliation>IRD Pakistan, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imran</LastName>
            <ForeName>Shayan</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-9181-5747</Identifier>
            <AffiliationInfo>
              <Affiliation>IRD Pakistan, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arif Siddiqi</LastName>
            <ForeName>Danya</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0001-9457-9110</Identifier>
            <AffiliationInfo>
              <Affiliation>IRD Global, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Altaf</LastName>
            <ForeName>Arshad</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-6536-7231</Identifier>
            <AffiliationInfo>
              <Affiliation>Independent Consultant, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khan</LastName>
            <ForeName>Aamir Javed</ForeName>
            <Initials>AJ</Initials>
            <Identifier Source="ORCID">0000-0001-8431-2498</Identifier>
            <AffiliationInfo>
              <Affiliation>IRD Global, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chandir</LastName>
            <ForeName>Subhash</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-6523-8875</Identifier>
            <AffiliationInfo>
              <Affiliation>IRD Global, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>05</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004209" MajorTopicYN="Y">Disposable Equipment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007267" MajorTopicYN="N">Injections</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013594" MajorTopicYN="Y">Syringes</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Auto–disable syringe</Keyword>
        <Keyword MajorTopicYN="Y">activation point</Keyword>
        <Keyword MajorTopicYN="Y">adverse events following immunization</Keyword>
        <Keyword MajorTopicYN="Y">bloodborne diseases</Keyword>
        <Keyword MajorTopicYN="Y">disposable syringe</Keyword>
        <Keyword MajorTopicYN="Y">syringe design</Keyword>
        <Keyword MajorTopicYN="Y">syringe reuse</Keyword>
        <Keyword MajorTopicYN="Y">unsafe injection practices</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>20</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33989509</ArticleId>
        <ArticleId IdType="pmc">PMC8381785</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2021.1911514</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kazi W, Bhuiyan SU.. A systematic review of the literature on the unsafe injection practices in the health-care settings and the associated blood-borne disease trend: experiences from selected South Asian countries. J Comm Prevent Med. 2018;1:1–17.</Citation>
        </Reference>
        <Reference>
          <Citation>Deuchert E, Brody S. Lack of autodisable syringe use and health care indicators are associated with high HIV prevalence: an international ecologic analysis. Ann Epidemiol. 2007;17(3):199–207. doi:10.1016/j.annepidem.2006.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annepidem.2006.09.005</ArticleId>
            <ArticleId IdType="pubmed">17174567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutin YJF, Hauri AM, Armstrong GL, Hauri AM, Armstrong GL, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ. 2003;327(7423):1075. doi:10.1136/bmj.327.7423.1075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.327.7423.1075</ArticleId>
            <ArticleId IdType="pmc">PMC261740</ArticleId>
            <ArticleId IdType="pubmed">14604927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ. 1999;77:801–07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2557740</ArticleId>
            <ArticleId IdType="pubmed">10593027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pépin J, Abou Chakra CN, Pépin E, Nault V, Vermund SH. Evolution of the global use of unsafe medical injections, 2000–2010. PLoS ONE. 2013;8(12):e80948. doi:10.1371/journal.pone.0080948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0080948</ArticleId>
            <ArticleId IdType="pmc">PMC3851995</ArticleId>
            <ArticleId IdType="pubmed">24324650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization . United Nations Population Fund, United Nations Children’s Fund. Safety of injections: WHO-UNICEF-UNFPA joint statement on the use of auto-disable syringes in immunization services. Geneva (Switzerland): World Health Organization; 1999. Available at https://apps.who.int/iris/handle/10665/63650.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization, UNICEF . Joint policy statement. Promoting the exclusive use of injection safety devices for all immunization activities. World Health Organization; 2019.  [Accessed 2019 Nov 10]. https://www.who.int/immunization/documents/policies/RUP_JointStatement.pdf?ua=1.</Citation>
        </Reference>
        <Reference>
          <Citation>ISO 7886-3:2005 . Sterile hypodermic syringes for single use part 3: auto-disable syringes for fixed-dose immunization. 2005.  [Accessed 2019 Nov 10]. https://www.iso.org/standard/36742.html.</Citation>
        </Reference>
        <Reference>
          <Citation>ISO 7886-3:2020 . Part 3: auto-disable syringes for fixed-dose immunization. 2020.  [Accessed 2020 Oct 25]. https://www.iso.org/standard/76605.html.</Citation>
        </Reference>
        <Reference>
          <Citation>PATH . Using auto-disable syringes. Module 5. [Accessed 2019 Dec 16]. https://path.azureedge.net/media/documents/SafeInjPDF-Module5.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization . Prequalified devices and equipment: productList. 2020.  [Accessed 2020 Oct 10]. https://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/categorypage.aspx?id_cat=37.</Citation>
        </Reference>
        <Reference>
          <Citation>GAVI . Injection safety efforts eliminate immunisation-related infections in sub-Saharan Africa. 2011.  [Accessed 2019 Nov 20]. https://www.gavi.org/news/media-room/injection-safety-efforts-eliminate-immunisation-related-infections-sub-saharan.</Citation>
        </Reference>
        <Reference>
          <Citation>UNICEF Supply Division . Safe injection equipment: supply and demand update. 2018.  [Accessed 2019 Dec 16]. https://www.unicef.org/supply/sites/unicef.org.supply/files/2019-06/safe-injection-equipment-SIE-supply-and%20demand-update.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>GAVI . Annual progress report. 2017. https://www.gavi.org/sites/default/files/publications/progress-reports/Gavi-Progress-Report-2017.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Reid S. Estimating the burden of disease from unsafe injections in India: a cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence. Indian J Community Med. 2012;37(2):89–94. doi:10.4103/0970-0218.96093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0970-0218.96093</ArticleId>
            <ArticleId IdType="pmc">PMC3361807</ArticleId>
            <ArticleId IdType="pubmed">22654281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahuguna P, Prinja S, Lahariya C, Dhiman RK, Kumar MP, Sharma V, Aggarwal AK, Bhaskar R, De Graeve H, Bekedam H. Cost-effectiveness of therapeutic use of safety-engineered syringes in healthcare facilities in India. Appl Health Econ Health Policy. 2020;18(3):393–411. doi:10.1007/s40258-019-00536-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40258-019-00536-w</ArticleId>
            <ArticleId IdType="pmc">PMC7250963</ArticleId>
            <ArticleId IdType="pubmed">31741306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drain PK, Ralaivao JS, Rakotonandrasana A, Carnell MA. Introducing auto-disable syringes to the national immunization programme in Madagascar. Bull World Health Organ. 2003;81:553–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2572525</ArticleId>
            <ArticleId IdType="pubmed">14576886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PRISMA . Transparent reporting of systematic reviews and meta-analyses. [Accessed 2020 Jun 16]. http://www.prisma-statement.org.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization . WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings. World Health Organization; 2015.  [Accessed 2019 Nov 20]. https://www.ncbi.nlm.nih.gov/books/NBK305368/.</Citation>
        </Reference>
        <Reference>
          <Citation>Atkins S, Launiala A, Kagaha A, Smith H. Including mixed methods research in systematic reviews: examples from qualitative syntheses in TB and malaria control. BMC Med Res Methodol. 2012;12(1):1–7. doi:10.1186/1471-2288-12-62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2288-12-62</ArticleId>
            <ArticleId IdType="pmc">PMC3445834</ArticleId>
            <ArticleId IdType="pubmed">22545681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janjua NZ, Khan A, Altaf A, Ahmad K. Towards safe injection practices in Pakistan. J Pak Med Assoc. 2006. https://mail.jpma.org.pk/PdfDownloadsupplements/1.</Citation>
        </Reference>
        <Reference>
          <Citation>Altaf A, Vaid S. The Sindh disposable syringe act: putting the act together. J Pak Med Assoc. 2013;63:1425–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24392533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gisselquist D. Avoiding reused instruments for immunizations exposes unsolved problems. Int J Occup Environ Health. 2009;15(1):107. doi:10.1179/oeh.2009.15.1.107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1179/oeh.2009.15.1.107</ArticleId>
            <ArticleId IdType="pubmed">19267129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma DC. India to use AD syringes to stem infection from reused needles. Lancet Infect Dis. 2004;4(10):601. doi:10.1016/S1473-3099(04)01168-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(04)01168-5</ArticleId>
            <ArticleId IdType="pubmed">15470767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dyer O. HIV: doctor who reused needles is blamed as nearly 900 children test positive in Pakistani city. BMJ. 2019;367:l6284. doi:10.1136/bmj.l6284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.l6284</ArticleId>
            <ArticleId IdType="pubmed">31666232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bandyopadhyay S, Singh A. How safe are auto disable (AD) syringes? Bulletin of postgratudate institute of medical education and reaserch. Chandigarh. 2005;39:17–21.</Citation>
        </Reference>
        <Reference>
          <Citation>Miller M, Pisani E. The cost of unsafe injections. Bull World Health Organ. 1999; 77(10): 808–11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2557745/pdf/10593028.pdf</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2557745</ArticleId>
            <ArticleId IdType="pubmed">10593028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmad K. Pakistan: a cirrhotic state? The Lancet. 2004;364(9448):1843–44. doi:10.1016/S0140-6736(04)17458-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(04)17458-8</ArticleId>
            <ArticleId IdType="pubmed">15565744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allegranzi B.The burden of unsafe injections worldwide: highlights on recent improvements and areas requiring urgent attention. World Health Organization; 2018.  [Accessed 2019 Dec 16].  https://www.who.int/medical_devices/Sun_pm_SAF_2_ALLEGRANZI.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Abubakar S, Usman R, Idris A, Haddad M, Mba C, Mba CJ. Knowledge and practice of injection safety among healthcare workers in a Nigerian secondary healthcare facility. Int J Infec Control. 2019;15(1):1–8. doi:10.3396/ijic.v15i1.004.19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3396/ijic.v15i1.004.19</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattarai MD, Wittet S. Perceptions about injections and private sector injection practices in central Nepal. 2000.  [Accessed 2020 Jan 15]. http://www.vaccineresources.org/files/Nepal-Inject-Practices-RA.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Birhanu D. Injection safety knowledge and practice among nurses working in Jimma university medical center; Jimma South West Ethiopia; 2018. J Comm Med Public Health Care. 2019;6(2):1–7. doi:10.24966/CMPH-1978/100045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.24966/CMPH-1978/100045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chemoiwa K, Mwaura-Tenambergen M. Injection safety practices among nurses in Kenyan public hospitals. Int J Professional Pract. 2018;6:15–22.</Citation>
        </Reference>
        <Reference>
          <Citation>Chemoiwa RK, Mukthar VK, Maranga AK, Kulei SJ. Nurses infection prevention practices in handling injections: a case of rift valley provincial hospital in Kenya. East Afr Med J. 2014;91:361–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26862615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chowdhury AKA, Roy T, Faroque ABM, Bachar SC, Asaduzzaman M, Nasrin N, Akter N, Gazi HR, Lutful Kabir AK, Parvin M, et al. A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh. BMC Public Health. 2011;11(1):779. doi:10.1186/1471-2458-11-779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2458-11-779</ArticleId>
            <ArticleId IdType="pmc">PMC3198945</ArticleId>
            <ArticleId IdType="pubmed">21985397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daly A, Nxumalo MP, Biellik RJ. An assessment of safe injection practices in health facilities in Swaziland. South Afr Med J. 2004;94:194–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15098279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garapati S, Peethala S. Assessment of knowledge and practices on injection safety among service providers in east Godavari district of Andhra Pradesh. Ind J Comm Health. 2014;26:259–63.</Citation>
        </Reference>
        <Reference>
          <Citation>Kandeel AM, Talaat M, Afifi SA, El-Sayed NM, Abdel Fadeel MA, Hajjeh RA, Mahoney FJ. Case control study to identify risk factors for acute hepatitis C virus infection in Egypt. BMC Infect Dis. 2012;12(1):294. doi:10.1186/1471-2334-12-294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-12-294</ArticleId>
            <ArticleId IdType="pmc">PMC3515403</ArticleId>
            <ArticleId IdType="pubmed">23145873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaphle H, Poudel S, Subedi S, Gupta N, Jain V, Paudel P. Awareness and practices on injection safety among nurses working in hospitals of Pokhara, Nepal. Int J Med Health Sci. 2014;3:301–07.</Citation>
        </Reference>
        <Reference>
          <Citation>Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, Mirza S, Malik T, Fisher-Hoch S, McCormick JB. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ. 2000;78:956–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2560828</ArticleId>
            <ArticleId IdType="pubmed">10994278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Logez S, Soyolgerel G, Fields R, Luby S, Hutin Y, Soyolgerel G, Fields R, Luby S, Hutin Y, Fields R, et al. Rapid assessment of injection practices in Mongolia. Am J Infect Control. 2004;32(1):31–37. doi:10.1016/j.ajic.2003.06.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajic.2003.06.006</ArticleId>
            <ArticleId IdType="pubmed">14755233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami H, Kobayashi M, Zhu X, Li Y, Wakai S, Chiba Y. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China. Soc Sci Med. 2003;57(10):1821–32. doi:10.1016/S0277-9536(03)00065-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0277-9536(03)00065-0</ArticleId>
            <ArticleId IdType="pubmed">14499508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mustufa MA, Memon AA, Nasim S, Shahid A, Omar SM. Exposure to risk factors for hepatitis B and C viruses among primary school teachers in Karachi. J Inf Dev Countr. 2010;4(10):616–20. doi:10.3855/jidc.499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3855/jidc.499</ArticleId>
            <ArticleId IdType="pubmed">21045353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mweu JM, Odero TMA, Kirui AC, Kinuthia J, Mwangangi FM, Bett SC, Musee CM. Injection safety knowledge and practices among clinical health care workers in Garissa provincial general hospital. East Afr Med J. 2015;92:26–34.</Citation>
        </Reference>
        <Reference>
          <Citation>Okwen MP, Ngem BY, Alomba FA, Capo MV, Reid SR, Ewang EC. Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions. Harm Reduct J. 2011;8(1):4. doi:10.1186/1477-7517-8-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1477-7517-8-4</ArticleId>
            <ArticleId IdType="pmc">PMC3041680</ArticleId>
            <ArticleId IdType="pubmed">21299899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandit NB, Choudhary SK. Unsafe injection practices in Gujarat, India. Singapore Med J. 2008;49:936–39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19037563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priddy F, Tesfaye F, Mengistu Y, Rothenberg R, Fitzmaurice D, Mariam DH, Del Rio C, Oli K, Worku A. Potential for medical transmission of HIV in Ethiopia. AIDS (London, England). 2005;19:348–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15718849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raglow GJ, Luby SP, Nabi N. Therapeutic injections in Pakistan: from the patients’ perspective. Trop Med Int Health. 2001;6(1):69–75. doi:10.1046/j.1365-3156.2001.00653.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-3156.2001.00653.x</ArticleId>
            <ArticleId IdType="pubmed">11263465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajasekaran M, Sivagnanam G, Thirumalaikolundusubramainan P, Namasivayam K, Ravindranath C. Injection practices in southern part of India. Public Health. 2003;117(3):208–13. doi:10.1016/S0033-3506(03)00065-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0033-3506(03)00065-9</ArticleId>
            <ArticleId IdType="pubmed">12825472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah H, Solanki H, Mangal A, Dipesh P. Unsafe injection practices: an occupational hazard for health care providers and a potential threat for community: a detailed study on injection practices of health care providers. Int J Health &amp; Allied Sci. 2014;3(1):28. doi:10.4103/2278-344X.130607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2278-344X.130607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talaat M, El-Oun S, Kandeel A, Abu-Rabei W, Bodenschatz C, Lohiniva A-L, Hallaj Z, Mahoney FJ. Overview of injection practices in two governorates in Egypt. Trop Med Int Health. 2003;8(3):234–41. doi:10.1046/j.1365-3156.2003.01015.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-3156.2003.01015.x</ArticleId>
            <ArticleId IdType="pubmed">12631314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan Y, Zhang G, Chen Y, Zhang A, Guan Y, Ao H. Study on the injection practices of health facilities in Jingzhou district, Hubei, China. Indian J Med Sci. 2006;60(10):407–16. doi:10.4103/0019-5359.27671.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0019-5359.27671</ArticleId>
            <ArticleId IdType="pubmed">17006026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yousafzai MT, Nisar N, Kakakhel MF, Qadri MH, Khalil R, Hazara SM. Injection practices among practitioners in private medical clinics of Karachi, Pakistan. East Mediter Health J. 2013;19(6):577–82. doi:10.26719/2013.19.6.570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.26719/2013.19.6.570</ArticleId>
            <ArticleId IdType="pubmed">24975187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HUR. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediter Health J. 2010;16(Suppl):S15–23. doi:10.26719/2010.16.Supp.15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.26719/2010.16.Supp.15</ArticleId>
            <ArticleId IdType="pubmed">21495584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cronin WA, Quansah MG, Larson E. Obstetric infection control in a developing country. J Obstetric, Gynecologic &amp; Neonatal Nurs. 1993;22(2):137–44. doi:10.1111/j.1552-6909.1993.tb01793.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1552-6909.1993.tb01793.x</ArticleId>
            <ArticleId IdType="pubmed">8478737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Musa OI, Parakoyi DB, Akanbi AA. Evaluation of health education intervention on safe immunization injection among health workers in Ilorin, Nigeria. Ann Afr Med. 2006;5:122–28.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu Z, Cui F, Chen Y, Miao N, Gong X, Luo H, Wang F, Zheng H, Kane M, Hadler SC. Evaluation of immunization injection safety in China, 2010: achievements, future sustainability. Vaccine. 2013;31:J43–8. doi:10.1016/j.vaccine.2012.11.057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2012.11.057</ArticleId>
            <ArticleId IdType="pubmed">24331020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ismail N, Aboul Ftouh A, El Shoubary W, Mahaba H. Safe injection practice among health-care workers in Gharbiya Governorate, Egypt. East Mediter Health J. 2007;13:893–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17955773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinglass R, Boyd D, Grabowsky M, Laghari A, Khan M, Qavi A, Evans P. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme. Bull World Health Organ. 1995;73:57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2486573</ArticleId>
            <ArticleId IdType="pubmed">7704926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altaf A, Fatmi Z, Ajmal A, Hussain T, Qahir H, Agboatwalla M. Determinants of therapeutic injection overuse among communities in Sindh, Pakistan. JAMC. 2004;16:35–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15631369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aziz S, Khanani R, Noorulain W, Rajper J. Frequency of hepatitis B and C in rural and periurban Sindh. J Pak Med Assoc. 2010;60:853–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21381619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoeve E, Codlin A, Jawed F, Khan A, Samad L, Vatcheva K, Fallon M, Ali M, Niaz K, McCormick J, et al. Persisting role of healthcare settings in hepatitis C transmission in Pakistan: cause for concern. Epidemiol Infect. 2013;141(9):1831–39. doi:10.1017/S0950268812002312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268812002312</ArticleId>
            <ArticleId IdType="pubmed">23114026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan A, Altaf A, Qureshi H, Orakzai M, Khan A. Reuse of syringes for therapeutic injections in Pakistan: rethinking its definition and determinants. East Mediter Health J. 2019;25:283–89.</Citation>
        </Reference>
        <Reference>
          <Citation>Fitzner J, Aguilera JF, Yameogo A, Duclos P, Hutin YJF, Aguilera JF, Yameogo A, Duclos P, Hutin YJF, Yameogo A, et al. Injection practices in Burkina Faso in 2000. Int J Qual Health Care. 2004;16(4):303–08. doi:10.1093/intqhc/mzh052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/intqhc/mzh052</ArticleId>
            <ArticleId IdType="pubmed">15252004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arora N. Injection practices in India. WHO South-East Asia J Public Health. 2012;1(2):189. doi:10.4103/2224-3151.206931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2224-3151.206931</ArticleId>
            <ArticleId IdType="pubmed">28612794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Correa M, Gisselquist D. Reconnaissance assessment of risks for HIV transmission through health care and cosmetic services in India. Int J STD AIDS. 2006;17(11):743–48. doi:10.1258/095646206778691068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1258/095646206778691068</ArticleId>
            <ArticleId IdType="pubmed">17062177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta E, Bajpai M, Sharma P, Shah A, Sarin S. Unsafe injection practices: a potential weapon for the outbreak of blood borne viruses in the community. Ann Med Health Sci Res. 2013;3(2):177–81. doi:10.4103/2141-9248.113657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2141-9248.113657</ArticleId>
            <ArticleId IdType="pmc">PMC3728858</ArticleId>
            <ArticleId IdType="pubmed">23919185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lakshman M, Nichter M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study. Soc Sci Med. 2000;51(1):11–28. doi:10.1016/S0277-9536(99)00426-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0277-9536(99)00426-8</ArticleId>
            <ArticleId IdType="pubmed">10817465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarman Singh SND, Sood R, Wali JP, Sood R, Wali JP, Wali JP. Hepatitis B, C and human immunodeficiency virus infections in multiply-injected Kala-azar patients in Delhi. Scand J Infect Dis. 2000;32(1):3–6. doi:10.1080/00365540050164137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00365540050164137</ArticleId>
            <ArticleId IdType="pubmed">10716069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atul K, Priya R, Thakur R, Gupta V, Kotwal J, Seth T. Injection practices in a metropolis of North India: perceptions, determinants and issues of safety. Indian J Med Sci. 2004;58:334–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15345887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kermode M, Holmes W, Langkham B, Thomas MS, Gifford S. Safer injections, fewer infections: injection safety in rural north India. Trop Med Int Health. 2005;10(5):423–32. doi:10.1111/j.1365-3156.2005.01421.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-3156.2005.01421.x</ArticleId>
            <ArticleId IdType="pubmed">15860088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutin YJ, Harpaz R, Drobeniuc J, Melnic A, Ray C, Favorov M, Iarovoi P, Shapiro CN, Woodruff BA. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol. 1999;28(4):782–86. doi:10.1093/ije/28.4.782.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ije/28.4.782</ArticleId>
            <ArticleId IdType="pubmed">10480711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung Y-S, Choi JY, Han MG, Park KR, Park S-J, Lee H, Jee Y, Kang C. A large healthcare-associated outbreak of hepatitis C virus genotype 1a in a clinic in Korea. J Clin Virol. 2018;106(106):53–57. doi:10.1016/j.jcv.2018.07.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcv.2018.07.006</ArticleId>
            <ArticleId IdType="pubmed">30075460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee H-I, Choi J-E, Choi S-J, Ko E-B. Medication injection safety knowledge and practices among health service providers in Korea. Qual Improv Health Care. 2019;25(1):52–65. doi:10.14371/QIH.2019.25.1.52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14371/QIH.2019.25.1.52</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abkar MAA, Wahdan IMH, Sherif AAR, Raja’a YA. Unsafe injection practices in Hodeidah governorate, Yemen. J Infect Public Health. 2013;6(4):252–60. doi:10.1016/j.jiph.2013.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiph.2013.01.003</ArticleId>
            <ArticleId IdType="pubmed">23806699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vun M, Galang R, Fujita M, Killam W, Gokhale R, Pitman J, Selenic D, Mam S, Mom C, Fontenille D, et al. Cluster of HIV infections attributed to unsafe injection practices - Cambodia, December 1, 2014-February 28, 2015. MMWR Morbidity Mortal Week Rep. 2016; 65:142–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26890340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dicko M, Oni AQ, Ganivet S, Kone S, Pierre L, Jacquet B. Safety of immunization injections in Africa: not simply a problem of logistics. Bull World Health Organ. 2000;78:163–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2560685</ArticleId>
            <ArticleId IdType="pubmed">10743280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adewuyi EO, Auta A. Medical injection and access to sterile injection equipment in low- and middle-income countries: a meta-analysis of demographic and health surveys (2010–2017). Int Health. 2020;12(5):388–94. doi:10.1093/inthealth/ihz113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/inthealth/ihz113</ArticleId>
            <ArticleId IdType="pmc">PMC7443715</ArticleId>
            <ArticleId IdType="pubmed">31851322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayashi T, Hutin YJ-F, Bulterys M, Altaf A, Allegranzi B. Injection practices in 2011–2015: a review using data from the demographic and health surveys (DHS). BMC Health Serv Res. 2019;19(1):1–10. doi:10.1186/s12913-019-4366-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12913-019-4366-9</ArticleId>
            <ArticleId IdType="pmc">PMC6712605</ArticleId>
            <ArticleId IdType="pubmed">31455315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed B, Ali T, Qureshi H, Hamid S. Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries. Hepatol Int. 2013;7(2):500–07. doi:10.1007/s12072-012-9417-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12072-012-9417-9</ArticleId>
            <ArticleId IdType="pubmed">26201782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization . Report of the first meeting of the steering committee on immunization safety. 1999.  [Accessed 2020 Jan 11]. https://apps.who.int/iris/bitstream/handle/10665/66328/WHO_V-B_00.17_eng.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Zakar MZ, Qureshi S, Zakar R, Rana S. Unsafe injection practices and transmission risk of infectious diseases in Pakistan: perspectives and practices. Pak Vis. 2013;14:27–50.</Citation>
        </Reference>
        <Reference>
          <Citation>Janjua NZ, Mahmood B, Imran Khan M. Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan? J Infect Public Health. 2014;7(4):345–55. doi:10.1016/j.jiph.2014.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiph.2014.04.001</ArticleId>
            <ArticleId IdType="pubmed">24861642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004;19(1):95–103. doi:10.1093/heapro/dah110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/heapro/dah110</ArticleId>
            <ArticleId IdType="pubmed">14976177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson CM, Sutanto A, Suradana IG. Use of SoloShot autodestruct syringes compared with disposable syringes, in a national immunization campaign in Indonesia. Bull World Health Organ. 1999;77:29–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2557576</ArticleId>
            <ArticleId IdType="pubmed">10063658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization . Medical device regulations: global overview and guiding principles. Geneva (Switzerland): World Health Organization; 2003.  [Accessed 2020 Jan 20]. https://apps.who.int/iris/handle/10665/42744.</Citation>
        </Reference>
        <Reference>
          <Citation>Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ. 1999;77:789–800.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2557743</ArticleId>
            <ArticleId IdType="pubmed">10593026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization . Aide-mémoire for a national strategy for the safe and appropriate use of injections. Geneva; 2000.  [Accessed 2020 Mar 13]. https://apps.who.int/iris/handle/10665/66696.</Citation>
        </Reference>
        <Reference>
          <Citation>Reeler AV. Anthropological perspectives on injections: a review. Int J Public Health. 2000;141:135–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2560596</ArticleId>
            <ArticleId IdType="pubmed">10686748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuroiwa C, Suzuki A, Yamaji Y, Miyoshi M. Hidden reality on the introduction of auto-disable syringes in developing countries. Southeast Asian J Trop Med Public Health. 2004;35:1019–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15916108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hersh Bradley S, Carr Richard M, Fitzner J, Goodman Tracey S, Mayers Gillian F, Everts H, Laurent E, Larsen Gordon A, Bilous Julian B. Ensuring injection safety during Measles immunization campaigns: more than auto‐disable syringes and safety boxes. J Infect Dis. 2003;187(s1):S299–S306. doi:10.1086/368227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/368227</ArticleId>
            <ArticleId IdType="pubmed">12721929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lloyd JS, Milstien JB. Auto-disable syringes for immunization: issues in technology transfer. Bull World Health Organ. 1999;77:1001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2557768</ArticleId>
            <ArticleId IdType="pubmed">10680248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization . WHO best practices for injections and related procedures toolkit. World Health Organization; 2010.  [Accessed 2020 Feb 25]. https://apps.who.int/iris/bitstream/handle/10665/44298/9789248599255_por.pdf.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
